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Abstract
Opportunistic fungal pathogens may cause an array of superficial infections or serious invasive infections, especially in
immunocompromised patients. Cryptococcus neoformans is a pathogen causing cryptococcosis in HIV/AIDS patients, but
treatment is limited due to the relative lack of potent antifungal agents. Photodynamic inactivation (PDI) uses the
combination of non-toxic dyes called photosensitizers and harmless visible light, which produces singlet oxygen and other
reactive oxygen species that produce cell inactivation and death. We report the use of five structurally unrelated
photosensitizers (methylene blue, Rose Bengal, selenium derivative of a Nile blue dye, a cationic fullerene and a conjugate
between poly-L-lysine and chlorin(e6)) combined with appropriate wavelengths of light to inactivate C. neoformans.
Mutants lacking capsule and laccase, and culture conditions that favoured melanin production were used to probe the
mechanisms of PDI and the effect of virulence factors. The presence of cell wall, laccase and melanin tended to protect
against PDI, but the choice of the appropriate photosensitizers and dosimetry was able to overcome this resistance.
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Introduction
Fungi are common causative agents of diseases in both immune
competent as well as immune compromised patient populations.
Fungal species of Candida, Aspergillus, and Cryptococcus are important
opportunistic human pathogens recently and have been ranked as
the seventh most common cause of infectious disease–related
deaths in the United States [1]. Opportunistic fungal pathogens
may cause serious superficial or invasive infections, especially in
immunocompromised and debilitated patients such as those
suffering from HIV infection, transplantation, corticosteroid
therapy and lymphoma [2–5].
The incidence of invasive mycoses has increased significantly
over the last three decades and now represents an exponentially
growing threat for human health due to a combination of slow
diagnosis and the existence of relatively few classes of available and
effective antifungal drugs. For these reasons systemic fungal
infections still result in high attributable mortality [2]. Cryptococ-
cosis is an infection caused by the yeast C. neoformans that is unique
among pathogenic fungi because it produces a polysaccharide
capsule to enclose the cell. The polysaccharide capsule contributes
to the overall virulence phenotype and is believed to protect
against dehydration and other stress conditions [3–5]. The
polysaccharide capsule is also released into the extracellular
environment as an exopolysaccharide that has numerous toxic
effects on the host innate and adaptive immune responses [6].
Cryptococcosis results from inhalation of fungal cells with
subsequent lung infection and pneumonia. In the absence of an
effective immune response, the fungus can disseminate to the brain
to cause meningoencephalitis (the major cause of death [7]), with
symptoms that include headache, fever, visual problems and an
altered mental state [8]. C. neoformans causes an estimated 1 million
cases of meningoencephalitis globally per year in patients with
AIDS, leading to approximately 625,000 deaths [1]. The bulk of
this disease burden is in sub-Saharan Africa, where fatal cases of
cryptococcosis may exceed deaths from tuberculosis in some areas
[1]. Furthermore, the infection requires prolonged antifungal
therapy and it is associated with neurological sequelae and may
require neurosurgical interventions [4,9]. Cranial nerve paresthe-
sia may occur due to fungal invasion and cranial compression
secondary to cerebral edema, and paralysis can persist as
permanent sequelae of the disease and involves one or more
cranial nerves [6,10–13].
Despite the increasing importance of opportunistic fungal
pathogens, there is a limited number of effective antifungal drugs
[14] and as the incidence of resistance to antifungal drugs is
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increasing the need for the development of new antifungal
treatment modalities is pressing [15]. One potential approach
under investigation is the light-based technology platform of
antimicrobial photodynamic inactivation (APDI) of C. neoformans or
other fungal pathogens [16–19]. APDI combines a nontoxic
photoactivatable dye or photosensitizer with harmless visible light
of the correct wavelength to excite the dye to the excited singlet
state, which will undergo electron spin inversion to the triplet state
and then generate reactive oxygen species, such as singlet oxygen
and hydroxyl radicals that are toxic to cells [20–22]. The toxic
effect of dyes and light on microorganisms was discovered
accidentally more than 100 years ago employing acridine orange
and eukaryotic parasites (Paramecium) [23]. Since then photody-
namic therapy (PDT) has been successfully employed as a cancer
modality [24] and an alternative therapeutic avenue for age-
related macular degeneration [25]. The exponentially increasing
threat of microbial multidrug resistance has upgraded APDI to a
highly promising alternative treatment for localized infections
[26,27]. The cells that need to be killed are incubated with the
photosensitizers and irradiated with light [19,28–30]. The
photodynamic action rapidly generates reactive oxygen species
(ROS) like singlet oxygen, hydroxyl radicals, superoxide ions and
lipid peroxides. Singlet oxygen has been implicated as the major
causative agent of cellular damage in photodynamic process [31].
Photosensitizers are usually organic aromatic molecules with a
high degree of electron delocalization that make them deeply
colored [32]. Porphyrins, chlorins, bacteriochlorins, phthalocya-
nines as well as a plethora of dyes with different molecular
frameworks have been proposed as antimicrobial photosensitizers
[33,34]. These dyes include halogenated xanthenes such as rose
bengal [35], phenothiazinium dyes such as methylene blue [36],
Nile blue dyes including the selenium derivative [37], cationic
fullerenes (e.g. derivatives of C60), [38,39] and conjugates between
chlorin(e6) and poly-L-lysine [40]. The APDI platform has been
proven to be effective against a range of pathogens including
multidrug-resistant microorganisms [8,41–45].
We have previously reported that the susceptibility of C.
neoformans to APDI was associated with cell wall integrity [16]. The
present study was aimed to extend this finding using a set of C.
neoformans virulence-related phenotypes and characteristics. This
effort was coupled with the use of a variety of unrelated
photosensitizer structures that may interact with different compo-
nents of C. neoformans cells, and produce different yields of various
ROS. Moreover we assessed the uptake and localization of
different photosensitizers, as well as the apoptotic mechanism of
yeast inactivation.
Materials and Methods
Strains and Culture Conditions
The C. neoformans strains used in this study are listed in Table 1
[46–48]. Strains were grown in YPD (1% yeast extract, 2%
peptone, 2% dextrose) broth for 24 h at 30uC. Cell growth was
assessed with a spectrophotometer (Mini 1240, Shimadzu,
Columbia, MD) at 600 nm (OD600). C. neoformans ATCC
208820 was grown in minimal medium [49] composed of
15 mM glucose, 10 mM MgSO4, 29.4 mM KH2PO4, 13 mM
glycine, 3 mM vitamin B1 (pH 5.5) with and without 1.0 mM L-
dopa (Sigma-Aldrich St Louis MO). L-dopa was used to induce
melanin formation in the yeast. The cells were incubated for 8
days at 30uC and then APDI was performed.
Chemicals and Photosensitizers
Methylene blue as chloride salt and rose bengal were from
Sigma-Aldrich (St. Louis, MO) The selenium derivative of Nile
blue (EtNBSe) [37], the conjugate pL-ce6 (average 37-lysine chain)
[50], and the tris-cationic fullerene (BB6) [39] were prepared as
previously described. The chemical structures of the five photo-
sensitizers are shown in Figure 1. Stock solutions were prepared in
water (DMSO for BB6) at a concentration of 2 mM and stored for
a maximum of 2 weeks at 4oC in the dark before use.
APDI Studies and CFU Determination
Yeast cells were incubated with the appropriate photosensitizer
dissolved in PBS at a concentration of 10 mMfor 30 min in the dark.
Following this period of time they were washed twice in PBS to
remove the photosensitizer that was not incorporated by cells. An
aliquotwas taken fromeach sample before irradiation to quantify the
number of viable cells (dark toxicity). The yeast suspensions were
placed in wells of 24-well microtiter plates (Fisher Scientific) and
illuminated using the halogen non-coherent lamp (LumaCare
LC122, MBG Technologies, Inc., UK) with interchangeable fiber
optic probes containing one of four different band pass filters. The
light delivery parameters are listed in Table 2.
Yeast strains were continually irradiated from the top of the flat-
bottom microtiter plate with fluences ranging from 0 to 60 J/cm2.
During illumination, aliquots of 20 mL were taken to determine
colony-forming units (CFU). The contents of the wells were
constantly stirred during illumination (to ensure that yeast cells did
not settle to the bottom of the wells) andmixed before sampling. The
aliquotswere seriallydiluted10-fold inPBS togivedilutionsof10–1 to
10–5 times theoriginal concentrations andwere streakedhorizontally
on square YPD agar plates [51]. This allowed a maximum of seven
logs of killing tobemeasured. Plateswere incubated at 30uCfor 48 h.
Three types of control conditions were used: no illumination and
photosensitizer, illumination in the absence of photosensitizer and
incubation with photosensitizer in the dark.
Uptake of Photosensitizers by Fungal Cells
Inocula of C. neoformans were incubated with photosensitizers for
30 minandtheyeastcellswerewashedtwice inPBS.OnemLaliquots
for each samplewere centrifuged (40006g) and thepellets suspended
in 1 mL 0.1 MNaOH and 1% SDS for 24 hours. The fluorescence
wasmeasured (SpectraMAXGeminiEM,MolecularDevices,USA)
at excitation and emission described in Table 3. Uptake values were
calculated by dividing the number of nmol of photosensitizers in the
dissolved pellet by the number of CFU obtained by a serial dilution
and the number of photosensitizer molecules per cell was calculated
using Avogadro’s number [16]. The excitation and emission
wavelengths employed are listed in Table 2.
Confocal Laser Scanning Microscopy (CLSM)
C. neoformans cells were incubated with the appropriate
photosensitizer (10 mM methylene blue, rose bengal, EtNBSe,
and pL-ce6 for 30 min) as previously described, and the cells were
then labeled with MitoTracker GreenTM or MitoTracker RedTM
(Invitrogen, Molecular Probes, Inc., US) at 0.1 mg/mL for 5 min.
BB6 lacks intrinsic fluorescence precluding the possibility of
analysis by traditional fluorescence methods. Four-mL aliquots
were taken from the pellet and placed on a slide and coverslip for
analysis. A confocal laser microscope (Leica TCS NT, Leica
Mikroskopie und System GmBH, Wetzlar, Germany) was used
with excitation at 488 nm from an argon laser. Two channels
collected fluorescence signals in either green range (580 nm
dichroic mirror plus 525/50 nm bandpass filter) from Mito-
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Tracker GreenTM(Molecular Probes), and in red range (580 nm
dichroic mirror plus 665 nm longpass filter) from photosensitizers.
Rose bengal was observed in the green channel (580 nm dichroic
mirror plus 525/50 nm bandpass filter) and fluorescence of
labeled mitochondria (MitoTracker RedTM, Molecular Probes)
was recorded in the red channel (580 nm dichroic mirror plus
660/30 nm bandpass filter). False color images (green and red)
were superimposed for the figures. Minor processing adjustments
were made using Adobe Photoshop CS2.
Apoptosis Assay
C. neoformans KN99a was treated with pL-ce6 mediated APDI
(10 mM as described above) and then incubated with FITC-
Annexin VH and propidium iodide (according to manufacturer’s
Table 1. Description of C. neoformans strains used in this study.
C. neoformans strain (reference) Characteristics
KN99a [46] Congenic ATCC 208821 (H99) MATa Serotype A
CAP59 [47] Congenic KN99a mating parent Serotype A
ATCC 208819 2E-TU4 [48] Congenic ATCC 34873 (NIH B-3501) MATa CNlac1 Laccase negative Serotype D
ATCC 208820 2E-TUC4 [48] Congenic ATCC 34873 (NIH B-3501) MATa CNLAC1 Laccase positive Serotype D
doi:10.1371/journal.pone.0054387.t001
Figure 1. Chemical structures of the photosensitizers used in this study. (A) Methylene blue; (B) Rose Bengal; (C) Selenium Nile blue
derivatrive (EtNBSe); (D) Tris-cationic fullerene (BB6); poly-L-lysine chlorin (e6) conjugate (pL-ce6).
doi:10.1371/journal.pone.0054387.g001
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instructions, Molecular Probes). Fluences of 0, 10, and 40 J/cm2
were delivered and then 4 mL aliquots were taken from each group
following incubation and/or irradiation, and the sample was
placed on a slide and coverslip for analysis. The confocal laser
microscope (Leica TCS NT), with excitation at 488 nm from an
argon laser was used. The cells were observed with 1006 oil
immersion objective and images at 5126512 pixels resolution were
recorded with 0.13 mm in each side of one pixel. Two channels
collected fluorescence signals in either the green range (580 nm
dichroic mirror plus 525/50 nm bandpass filter) from FITC-
Annexin V and in red range (580 nm dichroic mirror plus 660/
30 nm bandpass filter) from propidium iodide (PI). Annexin V
binds to phosphatidyl serine which is mostly localized at the inner
layer of the plasma membrane in the cell without apoptotic
process. However, the localization of phosphatidyl serine alters
after the initiation of the apoptotic process and the phosphatidyl
serine becomes exposed to the extracellular environment.
Propidium iodide labels chromatin in the advanced stage of
apoptosis when cell permeability has occurred.
Statistics
Statistical analysis of the CFU data and uptake experiments
data were performed using one-way analysis of variance
(ANOVA). Mean comparisons were carried out with Tukey’s test
with significance level at 5% (P,0.05) [52].
Results
We employed a panel of different C. neoformans strains and
phenotypes to explore the impact of virulence-specific character-
istics and structures, (capsule, laccase enzyme and pigment
production), on the APDI efficacy. Moreover, the activity of
different photosensitizers is related to chemical and photochemical
properties, while the efficiency to elicit antimicrobial efficacy also
depends on the pathogenic cell structure and function. This was
the conceptual basis for the selection and evaluation of a panel of
photosensitizers with different molecular frameworks and photo-
chemical properties. In all experiments, the number of viable cells
of samples of C. neoformans strains treated only with laser irradiation
(light alone) or with photosensitizer alone did not show a
significant difference compared to the control cells (data not
shown). On the other hand, there were substantial differences in
the killing effect of APDI and dye uptake after incubation with the
various photosensitizers. Due to the specific characteristics of each
strain and the variety of hypotheses to be tested in each
experiment, the data will be presented in different sections.
Effect of Capsule on APDI
C. neoformans has a complex outer membrane structure with the
outermost layer consisting of a capsule external to the cell wall,
and the cell membrane as the inner protective layer. In order to
evaluate the role of capsule on APDI efficiency, we compared the
killing activity of APDI mediated by different photosensitizers on
two strains of C. neoformans: the serotype A KN99a, carrying a
complete capsule, and the isogenic cap59 mutant, with a defective
capsule. Regardless of the different phototoxicity levels of each
photosensitizer tested, the strain comparison clearly demonstrated
the protective role of C. neoformans capsule in APDI. This
suppressing role in phototoxicty was tightly regulated by the
APDI experimental conditions (Fig. 2). This protective effect was
more prominent when pL-ce6 was employed as a photosensitizer,
with a difference in killing between the wild type and the isogenic
cap59 mutant strain of 5 logs and 20 J/cm2 (Figure 2E). Despite
that, KN99a was also highly susceptible to pL-ce6-mediated
APDI, showing 5 logs reduction in viability after 60 J/cm2. When
the other photosensitizers of the panel were employed, the APDI
protection was not so pronounced in the case of the capsule
expressing strains. The fullerene BB6 (Figure 2D) and the Nile
blue derivative EtNBSe (Figure 2C) showed the capsule provided
protection of two logs of killing, while in the case of the
Table 2. Irradiation and fluorescence parameters for each photosensitizer.
pL-ce6 MB RB EtNBSe BB6
Wavelength (nm) 665615 nm 665615 nm 540615 nm 650615 nm White (400–700 nm)
Total output power (mW) 700 700 450 700 1900
Fluence-rate (W/cm2) 40 40 30 40 112
Excitation (nm) 488 532 488 532 N/A
Emission (nm) 685 690 580 690 N/A
doi:10.1371/journal.pone.0054387.t002
Table 3. Molecular features that could affect APDI effectiveness.
Photosensitizer Number of +ve charges Calc logP
Molar extinction coeff (e)
(M21cm21) Type 1/Type 2
Rose Bengal 22 3.464 89000 2 (and 1)
Methylene Blue +1 21.969 74000 1 (and 2)
EtNBSe +1 5.535 55000 2 (and 1)
pL-ce6 Up to 36a 22.367 40000 2
BB6 +3 1.31 50000b 1
aAs the conjugate has 37 primary amino groups, the number of charges depends of pH and microenviroment.
bAverage extinction coefficient over range 400–700-nm.
doi:10.1371/journal.pone.0054387.t003
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Figure 2. Effect of capsule on photodynamic inactivation of C. neoformans KN99a (black squares) and cap59 (open squares). (A)
methylene blue, (B) rose bengal, (C) EtNBSe, (D) BB6, (E) pL-ce6 were used as photosensitizers at 10 mM in PBS for 30 min followed by a wash and
illumination with the wavelengths specified in Table 2. Data are means and bars are the standard deviation. * P,0.05; ** P,0.01; *** P,0.001 for
survival of KN99a vs cap59.
doi:10.1371/journal.pone.0054387.g002
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phenothiazinium dye methylene blue (Figure 2A) and the
xanthene dye rose bengal (Figure 2B) the capsule only showed
about 1 log of protection. The overall efficiency of killing of the
five different photosensitizers was: EtNBSe .pL-ce6. BB6. rose
bengal.methylene blue.
Effect of Laccase on APDI
Laccase, an enzyme located at the cell wall [53] is implicated in
pathogenesis of C. neoformans due to dopamine and non-dopamine
products that confer protection against killing for this yeast
through the ability to reduce reactive oxygen species and nitrogen
metabolites [54]. Melanization of cryptococcal cells has been
identified as a prime protective mechanism towards antifungal
chemotherapy (amphotericin B, caspofungin, silver nitrate) as well
as lethal doses of gamma irradiation [55]. This information
prompted an evaluation of the influence of laccase production on
APDI efficacy in cryptococcal cells. We compared the APDI
killing effect mediated by different photosensitizers on two strains
of C. neoformans with different degrees of melanization: C. neoformans
208820 is a laccase positive strain, and 208819, a laccase negative
strain [55–57]. The laccase positive strain was less susceptible to
APDI than the laccase negative strain with four out of five
photosensitizers (not rose bengal) (Figure 3).
The most pronounced protection by laccase was in the case of
PDI with pL-ce6 (Figure 3E), which amounted to 6 logs at 20 J/
cm2. The next largest protection by laccase was in the case of
EtNBSe (Figure 3C) where it was 3 logs at 10 J/cm2. APDI with
BB6 showed a 2 log difference between strains at 40 J/cm2
(Figure 3D) and for methylene blue the difference was 1 log at 40–
60 J/cm2 (Figure 3A). In the case of rose bengal there was no
significant difference and very little killing (Figure 3B).
Melanin Reduces Photoinactivation
The APDI profiling of the five photosensitizers against the two
cryptococal laccase phenotypes led to the conclusion that the
difference in viability reduction was the most pronounced with pL-
ce6. It raised also the question regarding the degree of melanin
interference with the phototoxic effect. Thus, we designed an
experiment to test this hypothesis. The design involved the growth
of C. neoformans ATCC 208820 (laccase positive strain) in minimal
media, in the presence or absence of L-dopa, a catecholamine
precursor required for melanin production and performing
subsequent APDI with pL-ce6. There was a significant protection
from killing in the cells incubated with L-dopa ranging from 1 log
at 10 J/cm2 to 4 logs at 40/cm2 as shown in Figure 4. This data
set confirmed that melanin production protects fungal cells from
phototoxicity.
Photosensitizer Uptake and Localization
The same set of C. neoformans strains as well as the photosen-
sitizers panel used in the APDI studies (with the exception of the
non-fluorescent BB6) were employed to monitor and analyze the
incorporation and localization of photosensitizer inside the yeast
cells. The comparison of accumulation for rose bengal and pL-ce6
in the capsule-related phenotypes KN99a and cap59 revealed no
statistical difference, between capsule positive and capsule negative
strains. On the other hand, EtNBSe gave higher accumulation
with by cap59 (P,0.05), whereas methylene blue was accumulated
significantly less by cap59 compared to KN99a (P,0.05) (Fig. 5A).
The uptake experiments for the laccase-related phenotypes
208819 and 208820 showed an increased fluorescence signal for
all photosensitizers in the laccase deficient strain. The accumula-
tion differences between the two strains was statistically significant
for rose bengal, pL-ce6 and EtNBSe (P.0.05) (Fig. 5B).
In order to visualize the localization of photosensitizers in the
yeast cell, we conducted confocal laser scanning microscopy
(CLSM) imaging employing the isogenic pairs KN99a/cap59 and
208819/208820 incubated with members of the photosensitizers
panel and Mitotracker red or green (a fluorescent probe for
mitochondria). Images obtained from cells incubated with
methylene blue showed intense red (methylene blue) and moderate
green (Mitotracker green) fluorescence. Methylene blue was
partially detected in the membrane and the nucleus of yeast cells
and, the preferential site of accumulation was in the mitochondria.
However, methylene blue was not only confined to this organelle,
and diffuse red fluorescence was observed in the cytoplasm.
Furthermore, the distribution of methylene blue in KN99a was
heterogeneous and some cells just exhibited green fluorescence
with no red visible (Fig. 6).
The accumulation and distribution of rose bengal (green
fluorescence) appeared homogeneous in all C. neoformans strains.
There was not a preferential site of rose bengal localization with
no detectable green fluorescence in the nucleus (Fig.6).
EtNBSe exhibited an intense red fluorescence in all phenotypes
with the cytoplasm and cell membrane appearing as the primary
photosensitizer accumulation sites. Superimposed images of
EtNBSe and Mitotracker green show photosensitizer uptake in
mitochondria with no detectable red fluorescence in the yeast
nuclei (Fig. 6). The CLSM images indicated external uptake of pL-
ce6, which appears as red fluorescence (Fig. 6). KN99a and
208820 seems to have no internalization of pL-ce6, while the
fluorescence tends to diffuse into the cytoplasm of cap59 and
208819.
Apoptosis Assays
We used an apoptotic assay developed for mammalian cells to
answer the question of whether apoptosis is a significant cell death
pathway in cryptococcal cells killed by APDI mediated by pL-ce6.
C. neoformans KN99a was incubated with FITC-Anexin VH after
irradiation with increasing red light fluences. When yeast cells
were incubated with pL-ce6 without irradiation, their membrane
showed no signs of damage or loss of integrity and fluorescence
from the trackers was not detectable. Phosphatidyl serine became
visible on the exterior of the yeast membrane after 10 J/cm2 red
light. An increase in the irradiation to 40 J/cm2 red light led to
similar levels of Annexin V (green) staining but now detectable PI
fluorescence (red) was seen in the nuclei of the yeast cells. The cell
modifications following PDI mediated cell death indicated the
presence of an apoptotic sequence of events (Fig. 7).
Discussion
C. neoformans is a pathogen that rose to prominence as the
causative agent of cryptococcosis, a life-threatening disease that
has emerged in parallel with the HIV/AIDS epidemic. A set of
recently discovered cryptococcal pathogenesis features suggested
the fungal adaptation to the mammalian environment [58]. These
features include 1) remarkably sophisticated interactions with
phagocytic cells to promote intracellular survival, 2) dissemination
to the central nervous system, and escape [58], and 3) surprising
morphological and genomic adaptations such as the formation of
polyploid giant cells in the lung [59]. The recent advances in
antifungal drug discovery includes only a limited number of
promising countermeasures for eradication of fungal diseases
including cryptococcosis [60].
The light-based technology of PDT has been suggested as a
potential alternative antifungal treatments [18]. Recent conceptual
and methodological studies have explored PDI in Cryptococcus spp.
Antimicrobial PDI on Cryptococcus neoformans
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Figure 3. Effect of laccase enzyme on photodynamic inactivation of C. neoformans ATCC 208820 (laccase positive strain, black
squares), and ATCC 208819 (laccase negative strain, open circles). (A) methylene blue, (B) rose bengal, (C) EtNBSe, (D) BB6, (E) pL-ce6 were
used as photosensitizers at 10 mM in PBS for 30 min followed by a wash and illumination with the wavelengths specified in Table 2. Data are means
and bars are the standard deviation. * P,0.05; ** P,0.01; *** P,0.001 for survival of 208820 vs 208820.
doi:10.1371/journal.pone.0054387.g003
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For the C. neoformans cell wall defective strain KN99a rom2, the
photosensitizer PEI-ce6 (similar in structure to the pL-ce6
employed in the current study) exhibited an increased uptake
with KN99a rom2, and the fluorescence was observed to penetrate
the cell [16]. Rom2 is a guanyl nucleotide exchange factor in the
cell wall integrity pathway, that relays the activation of the sensors
Figure 4. Protection of C. neoformans against APDI by melanin. C. neoformans ATCC 208820 (laccase positive strain) were grown in a minimal
medium with or without L-dopa and subjected to APDI with pL-ce6 (10 mM in PBS for 30 min followed by a wash and illumination with 665-nm). Data
are means and bars are the standard deviation. * P,0.05; ** P,0.01; *** P,0.001 for survival of +L-dopa vs no L-dopa.
doi:10.1371/journal.pone.0054387.g004
Figure 5. Effect of (A) capsule (KN99a and cap59), and (B) laccase enzyme (208820 and 208819) on photosensitize uptake. Each strain
was incubated with photosensitizers at 10 mM for 30 min, as described in material and methods. Data are means and bars are the standard deviation.
* p,0.05 between the positive and negative strains, for each photosensitizer.
doi:10.1371/journal.pone.0054387.g005
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by extracellular stressors through a signalling pathway that
initiates the phosphorylation events of the mitogen activated
protein kinase (MAPK) cascade [61,62]. The increased uptake and
the ability of the photosensitizers to penetrate and collect within
the cell was likely due to defects in the cell permeability barrier
that prevented the photosensitizers from being excluded. Interest-
ingly, in this study cell death was enhanced with the addition of the
antifungal caspofungin. A second study tested the effectiveness of
TBO as an antimicrobial photosensitizer against C. gattii strains
with distinct susceptibility profiles to amphotericin B and azoles.
The concept of equipotent PDI between susceptible and resistant
isolates was re-confirmed. A more detailed mechanistic study was
attempted including determination of ROS and reactive nitrogen
species (RNS, e.g. peroxynitrite) production and the catalase and
peroxidase activities were measured [19].
The unique tri-layered outer structure of C. neoformans provides
effective cell protective barriers and a challenging scenario for the
penetration of potential antifungal agents including photoactive
drugs. This consideration prompted a thorough investigation
employing a set of both phenotypic virulence-related and a panel
of photosensitizers of different structure, photophysics and
photochemistry. The primary question was to shed light in the
mechanistic aspects of C. neoformans susceptibility to PDI by
studying yeast phenotypic features. A secondary aim was to
identify structure-function trends and relationships between a
panel of antimicrobial photosensitizers and the cryptococcal cell.
There are at least four molecular features that govern the
relative effectiveness of antimicrobial photosensitizers. Firstly the
number of cationic charges borne by the molecule, as it has been
shown to be important to have a large number in order for
photosensitizers to kill Gram-negative bacteria. Secondly is the
degree of lipophilicity and molecular assymetry in the photosen-
sitizer molecule. Although it has not been rigorously proved it is
likely that this is an important consideration for anti-fungal
photosensitizers. Thirdly is the molar absorption coefficient of the
photosensitizer as it determines how efficiently light is harvested.
Fourthly there is the ability of different photosensitizers to produce
different ROS upon illumination. Singlet oxygen, hydroxyl
Figure 6. Confocal fluorescence microscopy images of C. neoformans strains. Cells were incubated with 10 mM photosensitizers for 30 min
as described (methylene blue, rose bengal, EtNBSe, and pL-ce6) and then labeled with MitoTracker GreenTM (for methylene blue, EtNBSe, and pL-ce6)
or MitoTracker RedTM (for rose bengal). All photosensitizers emitted red fluorescence, except rose bengal that emits green fluorescence. We present
one picture of the superimposed images for each strain incubated with each photosensitizer. Scale bars 8mm.
doi:10.1371/journal.pone.0054387.g006
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radicals, superoxide anion and peroxides (H2O2 and lipid
peroxides) have all been implicated in the antimicrobial effect of
PDI. There have been several QSAR studies carried out among
series of compounds of defined structure as candidate antimicro-
bial photosensitizer [34,37–39,63]. The following conclusions have
been made. High numbers of cationic charge are important for
killing Gram-negative bacteria but less so for Gram-positive
bacteria and fungi. Lipophilicity is more important for killing fungi
than bacteria. High molar extinction coefficients are beneficial.
The ability to induce Type 1 photochemistry (hydroxyl radicals
and peroxides) is important even though singlet oxygen (Type 2)
remains the single most important mediator of microbial death.
In the present studies the Nile blue derivative EtNBSe was the
most effective against both wild-type and mutant strains. Here the
important factor may be the lipophilicity combined with the Type
1 and 2 ROS. The next most effective photosensitizer was the pL-
ce6 conjugate that was particularly effective against the mutant
strains. Here the factor is likely to be the large number of basic
amino groups allowing binding and penetration especially in cells
with defective barriers. The fullerene BB6 was next in order of
effectiveness and this may be explained by the moderate
lipophilicity combined with 3 cationic charges and Type 1 ROS
production. Both methylene blue and rose bengal were relatively
ineffective.
The killing is enhanced when the capsule and cell wall are
damaged. We previously showed [16] that the addition of
caspofungin, which is directed at the cell wall, enhanced killing
and there was also increased cell death with the addition of
fluconazole (directed at the cell membrane). These findings would
suggest that the photosensitizer might work well when used in
conjunction with a drug or compound that could weaken the cell
wall or membrane and enhanced the effect of the photosensitizer,
perhaps minimizing the amount of time that a patient would need
to receive antifungal therapy. The mechanism of protection by the
capsule and cell wall barriers is partly due to reduction of uptake as
can be seen in Figure 5 and partly due to a restriction on diffusion
Figure 7. Confocal microscopy image of C. neoformas KN99a. Cells were treated with APDI mediated by pL-ce6 (10 mM) and then incubated
with FITC-annexin V and PI. Green represents fluorescence of externalized phosphatidylserine that is correlated to the initial steps of apoptosis, and
red corresponds to fluorescence of PI (advanced apoptosis/necrosis). We present three pictures of the same field: Transmittance in column A, green
and red fluorescence in columns B and C respectively. The first line of figures is the stained samples before APDI (0J/cm2), the second line is following
an irradiation of 10J/cm2 and the last one was irradiated with fluence of 40J/cm2. Scale bars 8mm.
doi:10.1371/journal.pone.0054387.g007
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of the photosensitizers inside the cells as can be seen from the
confocal images in Figure 6.
How does the PDI kill the fungal cells? We showed that with
pL-ce6 led to apoptosis, but it is uncertain whether this is a
consequence of physical oxidative damage to components of the
cell, or does the PDI generate an oxidative stressor that activates
signalling pathways within cell? PEI-ce6 generates mainly singlet
oxygen [64], that fungal cells do not have specific defences against.
The other photosensitizer produce greater or lesser amounts of
hydroxyl radicals that are more lethal than singlet oxygen on a
molecule for molecule basis, but fungal cells have both constitutive
[65] and inducible [66] defences against Type 1 ROS (catalase
and superoxide dismutase e) that do not specifically exist against
singlet oxygen. A recent report [67] showed that PDI of C. albicans
mediated by the silicon phthalocyanine known as PC4 induced
apoptosis in C. albicans.
Laccase is needed to produce melanin, which protects C.
neoformans from oxidative stress. Laccase also oxidizes iron in the
lungs, reducing the amount of Fe2+ available to alveolar
macrophages that use it in oxidative processes to combat the
pathogens. It should be noted that the laccase mutant and wild-
type strains produced by Wiliamson and colleagues [68] belong to
C. neoformans var. neoformans and could have some differences with C.
neoformans var. grubii (which KN99a belongs to).
In conclusion we have shown that the capsule, expression of
laccase enzyme and melanin production all protect against PDT-
mediated killing of C. neoformans. Furthermore we have obtained
information about structure-activity relationships in a panel of
unrelated antifungal photosensitizers that will be valuable in
ongoing efforts to rationally design high-activity photosensitizers
for possible clinical application.
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